Allergy-Immunology
Cardiology
Endocrinology
Gastroenterology
General Internal Medicine
Geriatric Medicine
Hematology / Oncology
Hepatology
Hospital Medicine
Immunotherapy
Infectious Diseases
Nephrology / Hypertension
Pulmonary & Critical Care
Rheumatology
Sports Medicine

Division of Cardiology

Bibliography 2002

2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |

Publications

  1. L, Gheorghiade M, Picone C, Papa A, Furgi G, Giuliano F, Maestri R, Rengo F. A randomized, double-blind comparison of lercanidipine 10 and 20 mg in patients with stable effort angina: effects on myocardial ischemia and heart rate variability. Am J Therap 2002;9:444-453.

  2. Adams KF, Gheorghiade M, Uretsky B, Patterson JH, Schwartz TA, Young JB.  Clinical benefits of low serum digoxin concentrations in heart failure. J Am Coll Cardiol 2002;39:946-953.

  3. Amar A, Zhang H, Leung D, Roistacher N, Kadish A. Older age is the strongest predictor of postoperative atrial fibrillation. Anesthesiology 2002;96:352-356.

  4. Ayzman, I, Dibs S, Goldberger J, Passman R, Kadish  A.  In vitro performance characteristics of reused ablation catheters.  J Intervent Card Electrophysiol 2002;7:53-59.

  5. Bairey Merz CN, Mensah GA, Fuster V, Greenland P, Thompson PD.  33rd Bethesda Conference: Task Force 5.The role of cardiovascular specialists as leaders in prevention: from training to champion.  J Am Coll Cardiol 2002;40:641-649.

  6. Basaria S, Nguyen T, Rosenson RS, Dobs AS.  Effect of methyl testosterone administration on plasma viscosity in postmenopausal women.  Clin Endocrinol (Oxf) 2002;57:209-214.

  7. Beller GA, Bonow RO, Fuster V. Revised guidelines for training in adult cardiovascular medicine: Core Cardiology Training II (COCATS 2). J Am Coll Cardiol 2002;39:1242-1246.

  8. Bild DE, Bluemke DA, Burke GR, Detrano R, Diez-Rouz AV, Folsom AR, Greenland P, Jacobs DR, Kronmal R, Liu K, Nelson JC, O’Leary DO, Saad MF, Shea S, Szklo M, Tracy RP.  Multi-ethnic study of atherosclerosis:  objectives and design.  Am J Epidemiol 2002;156:871-881.

  9. Blanco-Cedres L, Daviglus ML, Garside DB, Liu K, Pirzada A, Stamler J, Greenland P.  Relation of cigarette smoking to 25-year mortality in middle-aged men with low baseline serum cholesterol: the Chicago Heart Association Detection Project in Industry. Am J Epidemiol 2002;155:354-360.

  10. Bonow RO. Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2002;39:1159-1162.

  11. Bonow RO, Mitch WE, Nesto RW, O’Gara PT, Becker RC, Clark LT, Hunt S, Jialal I, Lipshultz SE, Loh E. Prevention VI. Diabetes and cardiovascular disease: Management of cardiovascular-renal complications. Circulation 2002;105:e159-e164.

  12. Bonow RO. Myocardial hibernation Ital J Cardiol 2002;3:285-290.

  13. Bonow RO, Smaha LA, Smith SC, Jr, Mensah GA, Lenfant C. The international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 2002;106:1602-1605.

  14. Bonow RO, Clark EB, Curfman GD, Guttmacher A, Hill MN, Miller DC, Morrison AR, Myerburg RJ, Schneider MD, Weisfeldt ML, Willerson JT, Young JB. Task Force on Strategic Research Direction: Clinical Science Subgroup. Key Science Topics Report. Circulation 2002;106:e162-e166.

  15. Bonow RO. Primary prevention of cardiovascular disease: a call to action. Circulation 2002;106:1340-3141.

  16. Bostom AD, Brown RS, Chavers BM, Coffman TM, Cosio FG, Culver K, Curtis JJ, Danovitch GM, Everson GT, First MR, Garvey C, Grimm R, Hertz MI, Hricik DE, Hunsicker LG, Ibrahim H, Kasiske BL, Kennedy M, Klag M, Knatterud ME, Kobashigawa J, Lake JR, Light JA, Matas AJ, McDiarmid SV, Miller LW, Payne WD, Rosenson RS, Sutherland DER, Tejani A, Textor S, Valantine HA, Wiesner RH.  Prevention of post-transplant cardiovascular disease:  report and recommendations of an ad hoc group.  Am J Transplant 2002;2:491-500.

  17. Choi J, Davidson CJ.  Spontaneous multivessel coronary artery dissection in a long-distance runner successfully treated with oral antiplatelet therapy: a case report and review of the literature.  J Invasive Cardiol 2002;14:675-678.

  18. Choudhury L, Gheorghiade M, Bonow RO. Coronary artery disease in patients with heart failure and preserved systolic function: a need for systematic evaluation. Am J Cardiol 2002;89:719-722.

  19. Choudhury L. Mahroldt H, Wagner A, Choi KM. Elliott M, Klocke FJ, Bonow RO, Judd RM, Kim RJ. Myocardial scarring in minimally symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40:2156-2164.

  20. Cuffe MS, Califf RM, Adams KF, Benza R, Bourge R, Colucci WS, Massie BM, O’Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M, for the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002;287:1541-1547.

  21. Davidson CJ, Gheorghiade M, Flaherty JD, Elliott MD, Reddy SP, Wang NC, Sundarem SA, Flamm SL, Blei AT, Abecassis MI, Bonow RO. Predictive value of stress myocardial perfusion imaging in liver transplant patients. Am J Cardiol 2002;89:359-360.

  22. Decker RS, Decker ML, Nakamura S, Zhao YS, Hedjbeli S, Harris KR, Klocke FJ.  HSC73-tubulin complex formation during low-flow ischemia in the canine myocardium.  Am J Physiol (Heart Circ Physiol) 2002;283:H1322-H1333.

  23. Diabetes Prevention Program Research Group. (McPherson DD) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.  N Engl J Med 2002;346:393-403.

  24. Dolan NC, Liu K, Criqui MH, Greenland P, Guralnik JM, Chan C, Schneider J, Mandapat AL, Martin GJ, McDermott MM.  Peripheral artery disease, diabetes, and reduced lower extremity functioning.  Diabetes Care 2002;25:113-120.

  25. Eichhorn E, Gheorghiade M. Digoxin: a new perspective of an old drug. N Engl J Med 2002;347:1394-1395.

  26. Eichhorn E, Gheorghiade M.  Digoxin. Prog Cardiovasc Dis 2002;44:251-266.

  27. Elliott MD, Kapoor A, Parker MA, Kaufman DB, Bonow RO, Gheorghiade M. Reduced hypertension in diabetics after kidney and pancreas transplantation. Cardiol Rev 2002;19:27-31.

  28. Farah GM, Goldberger JJ: Nonsustained ventricular tachycardia in the setting of acute myocardial infarction.  Cardiovasc Rev Rep 2002;23:403-407.

  29. Fonarow GC, Fowler MB, Gattis WA, Gheorghiade M, Gilbert EM, Yancy CW, Young JB. Consensus guidelines: improving heart failure care: strategies for increasing utilization of beta blockade in hospital initiation of beta blocker therapy for heart failure. Rev Cardiovasc Med 2002;3:S55-S59.

  30. Gattis WA, O’Connor CM, Gheorghiade M. The Initiation Management Predischarge Process for Assesment of Carvedilol Therapy for Heart Failure (IMPACT – HF) Study: design and implications. Rev Cardiovasc Med 2002;3:S48-S54.

  31. Gheorghaide M, Goldstein S. Beta-blockers in the post-myocardial infarction patient. Circulation 2002;106:394-399.

  32. Gheorghiade M, Gattis WA, O’Connor CM. Treatment gaps in the pharmacological management of heart failure. Rev Cardiovasc Med 2002;3:S11-S19.

  33. Greenland P, Frohlich ED, Bairey Merz CN, Pasternak RC.  Revised guidelines for training in adult cardiovascular medicine: Core Cardiology Training II (COCATS 2) Task Force 10:  Training in Preventive Cardiovascular Medicine.  (http://www.acc.org/ clinical/training/cocats2.pdf<!--[if !supportNestedAnchors]--><!--[endif]-->) p50-52.

  34. GreenlandP, Colangelo L.  Long-term prediction of coronary heart disease in young men [letter].  Ann Intern Med 2002;136:631-632.

  35. Greenland P.  Clinical significance, detection, and medical treatment for peripheral arterial disease.  J Cardiopulm Rehabil 2002;22:73-79.

  36. Grundy SM, Howard B, Smith SC, Eckel R, Redberg R, Bonow RO. Prevention VI: Diabetes and Cardiovascular Disease. Executive Summary. Circulation 2002;105:2231-2239.

  37. Grundy S, Vega G, McGovern M, Tulloch B, Kendall D, Fitzpatrick D, Ganda O, Rosenson R, Buse J, Robertson D, Sheehan J, and the Diabetes Multicenter Research Group.  Efficacy, safety, and tolerability of extended-release niacin (niaspan) for the treatment of dyslipidemia associated with type 2 diabetes.  Arch Intern Med 2002;162:1568-1576.

  38. Hamilton AJ, Rabbat M, Jain P, Belkind N, Huang SL, Nagaraj A, Klegerman M, MacDonald R, McPherson DD.  A physiological flow chamber model to define intravascular ultrasound enhancement of fibrin using echogenic liposomes. J Invest Radiol 2002;37:215-221.

  39. Hamilton AJ, Huang SL, Warnick D, Stein A, Rabbat M, Madhav T, Kane B, Nagaraj A, Klegerman M, MacDonald RC, McPherson DD.  Left ventricular thrombus enhancement following intravenous injection of echogenic immunoliposomes: studies in a new experimental model. Circulation 2002;105:2772-2778.

  40. Huang SL, Hamilton AJ, Pozharski E, Nagaraj A, Klegerman ME, McPherson DD, MacDonald RC.  Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents. Ultrasound Med Biol 2002:28:339-348.

  41. Kaufman DB, Leventhal JR, Gallon LG, Parker MA, Elliott MD, Gheorghiade M, Koffron AJ, Fryer JP, Abecassis MM, Stuart FP. Technical and immunologic progress in simultaneous pancreas-kidney transplantation. Surgery 2002;132:545-553.

  42. Kadish A.  Primary prevention of sudden death using ICD therapy: incremental steps. J Am Coll Cardiol 2002;39:788-789.

  43. Kannankeril P, Goldberger JJ: Parasympathetic effects on cardiac electrophysiology during exercise and recovery.  Am J Physiol (Heart Circ Physiol) 2002;282:H2091-H2098.

  44. Kennedy H, Rosenson RS.  Physicians’ interpretation of “class effects” - a need for thoughtful revisit.  J Am Coll Cardiol 2002;40:19-26.

  45. Kjeldsen K, Norgaard A, Gheorghiade M.  Myocardial Na,K-ATPase: the molecular basis for beneficial and safe digoxin therapy. Cardiovasc Res 2002;55:710-713.

  46. Klegerman ME, Hamilton AJ, Huang SL, Tiukinhoy SD, Khan AA, MacDonald RC, McPherson DD.  Quantitative immunoblot assay for assessment of liposomal antibody conjugation efficiency. Analyt Biochem 2002;300:46-52.

  47. Koenig W, Rosenson RS.  Emerging risk factors: acute-phase reactants. Semin Vasc Med 2002;2:417-428.

  48. Mahrholdt H, Wagner A, Holly TA, Elliott MD, Bonow RO, Kim RJ, Judd RM. Reproducibility of infarct size measurement by contrast enhanced MRI. Circulation 2002;106:2232-2237.

  49. Manson JE, Greenland P, LaCroix AZ, Stefanick ML, Mouton CP, Oberman A, Perri MG, Sheps DS, Pettinger MB, Siscovick DS.  Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 2002;347:716-25.

  50. McDermott MM, Greenland P, Ferrucci L, Criqui MH, Liu K, Sharma L, Chan C, Celic L, Priyanath A, Guralnik JM.  Lower extremity performance is associated with daily life physical activity in individuals with and without peripheral arterial disease.  J Am Ger Soc 2002;50:247-255.

  51. McDermott MM, Greenland P, Liu K, Guralnik JM, Celic L, Criqui MH, Chan C, Martin GJ, Schneider J, Pearce WH, Taylor LM, Clark E.  The ankle brachial index is associated with leg functioning and physical activity: the Walking and Leg Circulation Study. Ann Intern Med 2002;136:873-883.

  52. McDermott MM, Hahn EA, Greenland P, Cella D, Ockene JK, Brogan D, Pearce WH, Hirsch AT, Hanley K, Odom L, Khan S, Criqui MH, Lipsky MS, Hudgens S. Atherosclerotic risk factor reduction in peripheral arterial disease. J Gen Intern Med 2002;17:895-904.

  53. Miura K, Nakagawa H, Greenland P.  Invited Commentary:  Height-cardiovascular disease relation:  Where to go from here? Am J Epidemiol 2002;155:688-689.

  54. Molnar J, Weiss JS, Rosenthal JE. Does heart rate identify sudden death survivors? Am J Therapeutics 2002; 9:99-110.

  55. Mori F, Bonow RO, Castelli G, Gheorghiade M, Stefano PL, Zuppiroli A. Attuali orientamenti nel trattamento dellevalvulopatie. Il Cardiologo 2002;2 (suppl 1):1-11.

  56. Muster AJ, McNeal MA, McPherson DD.  Can age-related decline in left ventricular compliance be slowed by habitual endurance exercise?  JAMA 2002;15:5-7.

  57. Nishio M. Ruch SW. Wasserstrom JA. Positive inotropic effects of ouabain in isolated cat ventricular myocytes in sodium-free conditions. Am J Physiol  (Heart Circ Physiol) 2002;283:H2045-H2053

  58. O’Connor CM, Gattis WA, Adams KF, Shah MR, Kobrin I, Frey A, Gheorghiade M, for the RITZ-4 Investigators.  Tezosentan in patients with acute heart failure and acute coronary syndromes: design of  the Randomized Intravenous Tezosentan Study (RITZ-4). Am Heart J 2002;144:583-588.

  59. Otvos JD, Shalaurova I, Freedman DS, Rosenson RS.  Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trial.  Atherosclerosis 2002;160:41-48.

  60. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM, Hong Y, Houston-Miller N, Lauer RM, Ockene IS, Sacco R, Sallis JF, Smith SC Jr., Stone NJ, Taubert KA.  AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Circulation 2002;106:388-391.

  61. Piskur JR, Stone NJ. Statins as cardioprotective agents. Am J Manag Care 2002;8 (Suppl):25-29.

  62. Rankovic R, Karha J, Passman R, Kadish A, Goldberger J. Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy.  Am J Cardiol 2002;89:1072-1076

  63. Rajamannan NM, Subramanian M, Sebo T, Stone NJ, Bonow RO, Spelsberg TC. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 2002;105:2660-2665.

  64. Roberts R, Bonow RO, Loscalzo J, Mosca L,. Report of the American Heart Association Task Force on Strategic Research Direction. Executive Summary. Circulation 2002;106:2630-2632.

  65. Rosenson RS, Shott S, Tangney CC. Hypertriglyceridemia is associated with an elevated blood viscosity.  Atherosclerosis 2002:161:433-439.

  66. Rosenson RS, Freedman DS, Otvos JD.  Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) Trial.  Am J Cardiol 2002;90:89-94.

  67. Rosenson RS.  Statins and the risk of rhabdomyolysis.  J Endocrinol Invest 2002;25:577.

  68. Rosenson RS, Koenig W.  High-sensitivity CRP and cardiovascular risk in CHD patients.  Curr Opin Cardiol 2002;17:325-331.

  69. Rosenson RS, Brown AS.  Statin use in acute coronary syndromes:  cellular mechanisms and clinical evidence.  Curr Opin Lipidol 2002;13:625-630.

  70. Rosenson RS. The rationale for combination therapy. Am J Cardiol 2002;90(suppl):2K-7K.

  71. Sagawa T. Sagawa K. Kelly JE. Tsushima RG. Wasserstrom JA. Activation of cardiac ryanodine receptors by cardiac glycosides. Am J Physiol - Heart & Circulatory Physiology 2002;282:H1118-H1126

  72. Seghatol FF, Rigolin VH. Appetite suppressants and valvular heart disease. Curr Opin Cardiol 2002;17:486-492.

  73. Shah DJ, DiLuzio S, Ambardekar AV, Smulevitz B, Smith GL, Nagaraj A, Hamilton AJ, McPherson DD, Rigolin VH. Evaluation of valvular regurgitation severity using digital acquisition of echocardiographic images. J Am Soc Echocardiogr 2002;15:241-6.

  74. Shah MR, Hasselblad V, Stinnett SS, Kramer JM, Grossman S, Gheorghiade M, Adams KF, Swedberg K, Califf RM, O'Connor CM. Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure. Eur J Heart Fail 2002;4:297-304.

  75. Sjaastad I. Bokenes J. Swift F. Wasserstrom JA. Sejersted OM. Normal contractions triggered by I(Ca,L) in ventricular myocytes from rats with postinfarction CHF. Am J Physiol - Heart & Circulatory Physiology 2002;283:H1225-H1236

  76. Stamler J, Liu K, Ruth KJ, Pryer J, Greenland P.  Eight-year blood pressure change in middle-aged men: relationship to multiple nutrients. Hypertension 2002;39:1000-1006.

  77. Stone NJ, Van Horn L. Therapeutic lifestyle change and Adult Treatment Panel III: evidence then and now. Curr Atheroscler Rep 2002;4:433-443.

  78. Stone NJ. Current drug treatments for lipid management. Manag Care 2002;11: (Suppl):4-9.

  79. Swedberg K, Bristow MR, Cohn JN, Dargie H, Straub M, Wiltse C, Wright TJ; for the Moxonidine Safety and Efficacy (MOXSE) Investigators (Gheorghiade M). Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure. Circulation 2002;105:1707-1803.

  80. Taneja T, Kadish A, Parker M, Goldberger J: Acute hemodynamic effects at the onset of supraventricular and ventricular tachycardia. Am J Cardiol 2002;90:1294-1299.

  81. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. (Stone NJ) Circulation 2002;106:3143-3421

  82. Tsushima RG. Kelly JE. Wasserstrom JA. Subconductance activity induced by quinidine and quinidinium in purified cardiac sarcoplasmic reticulum calcium release channels. J Pharm Exp Ther 2002;301:729-737

  83. Wasserstrom JA. Wasserstrom LA. Lokuta AJ. Kelly JE. Reddy ST. Frank AJ. Activation of cardiac ryanodine receptors by the calcium channel agonist FPL-64176. Am J Physiol - Heart & Circulatory Physiology 2002;283:H331-H338, 2002

  84. Wolbrette D, Naccarelli G, Curtis A, Lehman M, Kadish A.  Gender differences in arrhythmias. Clin Cardiol 2002;25:49-56.

Book Chapters

  1. Bonow RO. Timing of operation for asymptomatic severe aortic regurgitation. In: Braunwald E, ed. Harrison’s Advances in Cardiology. New York: McGraw-Hill 2002:354-359

  2. Bonow RO. Diabetes and left ventricular dysfunction. In: Rengo F, Bonow RO, Gheorghiade G, eds. Heart Failure in the Elderly: The Evolution of Chronic Heart Failure. Pavia: Maugeri Foundation Books 2002:7-10

  3. Gheorghiade M, Bonow RO. Coronary artery disease in heart failure. In: Rengo F, Bonow RO, Gheorghiade G, eds. Heart Failure in the Elderly: The Evolution of Chronic Heart Failure. Pavia: Maugeri Foundation Books 2002:3-6

  4. Rosenson RS.  Screening guidelines for dyslipidemia-I  In: Rose B, ed. UpToDate.  Wellesley, MA: BDR, Inc. 2002; Vol. 10.1.

  5. Sundaram S, Zampino M, Gheorghiade M.  Is there still a place for digoxin in heart failure? In: van Veldhuisen DJ, Pitt B, eds.  Focus on Cardiovascular Diseases: Chronic Heart Failure. Amsterdam: Benecke N.I. 2002, 219-254.

Abstracts

  1. Bello D, Karam C, Parker M, Farah G, Vargas J, Judd RM, Bonow RO, Gheorghiade M, Kim RJ. Detection of myocardial infarction in heart failure patients with severe left ventricular systolic dysfunction by contrast enhanced MRI. J Am Coll Cardiol 2002;39:186A.

  2. Bello D, Fieno D, Betts T, Wu E, Son G, Pereles S, Kadish A, Goldberger J. Infarct morphology in patients with coronary artery disease with and without inducible ventricular tachycardia. Circulation 2002;106:II-410.

  3. Beohar N, Flaherty JD, Davidson CJ, MacDonald LA, Wang NC, Shah AP, Decker R, Lumasney JW, Bonow RO, Klocke FJ.  Antirestenotic effects of inhibition of balloon injury mediated apoptosis with local delivery of a caspase inhibitor. J Am Coll Cardiol 2002:39:442A.

  4. Betts T, Bello D, Goldberger J, Kadish A.  Pacing thresholds at high pacing rates: implications for ICD therapies. PACE 2002;24:555.

  5. Betts T, Bello D, Goldberger J, Kadish A.  Strength-interval curves during ventricular busrt pacing.  PACE 2002;24:667.

  6. Betts T, Bello D, Goldberger J, Kadish A.  Progressive aberrancy: an electrocardiographic phenomenon simulating fusion.  PACE 2002;24:677.

  7. Choudhury L, Mahrholdt H, Wagner A, Choi K, Elliott M, Vargas J, Bonow R, Judd R, Kim R. Visualization of myocardial scarring in hypertrophic cardiomyopathy by contrast enhanced MRI. J Cardiovasc Magnetic Res 2002;4:3.

  8. Daviglus ML, Liu K, Greenland P, Pirzada A, Garside DB, Dyer AR, Hoff JA, Kondos GT.  Coronary calcium in older people with favorable cardiovascular (CV) risk factor profile in middle age:  The Chicago Heart Association (CHA) Study. Circulation 2002;106:II-743.

  9. Eimer MJ, Ekery D, Rigolin V, Johnson M, Gheorghiade M, Bonow RO, Cotts WG. Elevated B-type natriuretic peptide in patients with asymptomatic aortic regurgitation and normal left ventricular systolic function. J Am Coll Cardiol 2002;39:423A.

  10. Felker MG, Gattis WA, Leimberger JD, Adams KF, Gheorghiade M, O’Connor CM. Anemia as a predictor of death and rehospitalization in patients with advanced decompensated heart failure: insights from the OPTIME-CHF Trial. J Card Fail 2002;8:S52.

  11. Gami AS, Holly TA, Rosenthal JE. Electrocardiographic poor R wave progression: analysis of multiple criteria reveals little utility. J Am Coll Cardiol 2002;39:121A.

  12. Gheorghiade M, Konstam MA, Udelson JE, Ouang J, Orlandi C. Vasopressin receptor blockade with tolvapatan in chronic heart failure: differential effects in normonatremic and hyponatremic patients. J Am Coll Cardiol 2002;39:171A.

  13. Gheorghiade M. Vasopressin blockade in patients with chronic heart failure. J Heart Fail 2002;7:S67.

  14. Goldberger J, Kannakeril P, Le F, Kadish A.  Characteristics of heart rate recovery after maximal exercise. J Am Coll Cardiol 2002;39:100A.

  15. Goldberger J, Kruse J, Choe W, Rankovic V, Ilan M, Passman R, Kadish A.  Effect of Informed Consent Format on Patient Anxiety and Understanding.  PACE 2002;24:633.

  16. Goldberger JJ, Kannankeril PJ: Poor correlation of parasympathetic effects on the sinus and AV nodes and ventricle.  PACE 2002;24:652.
    Goldberger J, Roxe D:  Relationship of 24-hour ambulatory blood pressure to heart rate in overt and isolated systolic hypertension.  Circulation 2002;106:II-573.

  17. Haissaguerre M, Shah D, Jais P, Shoda M, Kautzner J, Arentz T, Kalushe D, Kadish A, Griffith M, Gaita F, Cruz F, De Paolla A, Garrigue S, Hocini M, Weerasooriya R, Lamaison D, Clementy J.  Role of Purkinje system in triggering idiopathic ventricular fibrillation.  PACE 2002;24:532.

  18. Hamilton AJ, Huang SL, Rabbat M, Madhav T, Warnick D, Nagaraj A, Klegerman ME, MacDonald RC, McPherson DD.  Specific fibrin enhancement with targeted echogenic immunoliposomes.  J Am Coll Cardiol 2002;39:341A.

  19. Hamilton AJ, Huang SL, Rabbat M, Warnick D, Nagaraj A, Kane BJ, Klegerman ME, MacDonald RC, McPherson DD.  Intravascular ultrasound molecular imaging of ICAM-1 and fibrin in a Yucatan miniswine model of early and late stage atherosclerosis. J Am Coll Cardiol 2002;39:387A.

  20. Hamilton AJ, Mun JH, Smulevitz B, Nagaraj A, Kane BJ, Greene R, McPherson DD, Chandran KB.  In-vivo determination of vascular mechanics with atheroma development. J Am Coll Cardiol 2002;39:247A.

  21. Hamilton AJ, Rabbat M, Huang SL, Stein A, Madhav T, Kane BJ, Klegerman ME, MacDonald RC, McPherson DD. Left ventricular thrombus enhancement following intravenous echogenic immunoliposome injection. J Am Coll Cardiol 2002;39:367A.

  22. Heiba SI, Prakash AM, Dakhel M, Kaya GC, El-Zeftawy H, Ambrose JA, Abdel-Dayem HA. Does the recognition of transient post-ischemic stunning in gated SPECT myocardial perfusion imaging have a diagnostic value in patients with CAD? J Nucl Med 2002, 43:96P.

  23. Horvath G, Racker  D, Goldberger J, Kadish, A.  Do changes in local cardiac electrophysiology influence ventricular fibrillation cycle length?   J Am Coll Cardiol 2002;39:92A.

  24. Huang SL, McPherson DD, MacDonald RC.  Ultrasound in conjunction with an ultrasonic-reflective transfection agent enhances gene delivery to cells.  J Am Coll Cardiol 2002;39:228A.

  25. Huang S, Tiukinhoy S, McPherson D, MacDonald R.  Combined use of ultrasound and acoustic cationic liposomes results in improved gene delivery into smooth muscle cells. Molecular Ther 2002;5:S9.

  26. Huang SL, Tiukinhoy SD, Nagaraj A, McPherson DD, MacDonald RC.  Acoustically active liposomes improve transfection efficiency when used in conjunction with low level ultrasound. J Invest Med 2002;5:234A.

  27. Kadish A, Frishman W, Daugherty S, Limacher M, Greenland P.  Effect of hormone replacement on myocardial repolarization: a women’s health initiative substudy. Circulation 2002;106:II-460.

  28. Kapoor A, Passman R, Kruse J,Goldberger J, Dibs S, Denes P, Kadish A.  Spontaneous ventricular arrhythmias in patients with ICD’s for primary vs. secondary prophylaxis. Circulation 2002;106:II-668.

  29. Kean AJ, Seghatol FF, Ewert GD, Mehlman DJ, McPherson DD, Rigolin VH. Marathon running results in transient reduction in left ventricular volumes but preserved ejection fraction in amateur athletes. J Am Soc Echocardiogr 2002;15:517.

  30. Kim HW, Wu E, Meyers SN, Choi KM, Parker MA, Klocke FJ, Bonow RO, Judd RM, Kim RJ. Prognostic significance of unrecognized myocardial infarction detected by contrast MRI. Circulation 2002:106;II-389.

  31. Klein L, Gheorghiade M. Short term intravenous milrinone for acute exacerbation of congestive heart failure: a randomized, double blind, placebo, controlled trial. Rev Romana de Cardiologie 2002;17:101.

  32. Klein L, Gheorghiade M, Orlandi C. Chronic effects of vasopressin receptor blockade with tolvaptan in congestive heart failure: a randomized, double blind, placebo, controlled trial. Rev Romana de Cardiologie 2002;17:156.

  33. Le F, Kannakeril P, Kadish AH, Goldberger J.  Heart rate variability after exercise Is related to recovery of parasympathetic tone. J Am Coll Cardiol 2002;39:100A-1A.

  34. Liu K, Daviglus ML, Yan LL, Garside DB, Greenland P, Dyer AR, Stamler J.  Post-load plasma glucose levels in middle-aged non-diabetic adults and incidence of diabetes in older age:  The Chicago Heart Association Detection Project in Industry (CHA) Study. Circulation 2002;106:II-765.

  35. Mahrholdt H, Choudhury L, Wagner A, Honold M, Bonow RO, Sechtem U, Judd RM, Kim RJ. Relation of myocardial scarring to clinical risk factors for sudden cardiac death in hypertrophic cardiomyopathy. Circulation 2002;106:II-652.

  36. Margolis KL, Assaf A, Bray PF, Greenland P, Grimm RH, Howard B, Manson JE, Prentice R, Rodabough R.  Leukocyte count as a predictor of cardiovascular events in post-menopausal women.  Circulation 2002;106:II-729.

  37. Mobassori S, Tangney CC, Lu L, Rosenson RS.  Secretory phospholipase is related to other coronary heart disease risk factors.  J Am Coll Cardiol 2002;39:270A.

  38. Nahlawi M, Waligora M, Spies SM, Bonow RO, Kadish AH, Goldberger J.  Cardiac memory: effects on QT interval and dispersion. J Am Coll Cardiol 2002;39:100A.

  39. Nishio M, Kelly JE, Wasserstrom JA: Cardiac glycosides increase Ca2+ spark duration and reduce spark frequency in cat myocytes under Na+-free conditions. Biophys J 2002;82:359a.

  40. Oesterle S, Davidson C, Kuntz R, Nordhausen C, Vonesh M, Ulm M, Macri N.  In-vivo evaluation of a novel ePTFE-covered self-expanding stent for the treatment of diseased saphenous vein bypass grafts. J Am Coll Cardiol 2002;39:52A.

  41. Passman R, Freher M, Goldberger J, Denes P, Dibs S, Schaechter  A, Kadish A.  Is mode switching a surrogate marker for paroxysmal atrial tachyarrhythmias?  J Am Coll Cardiol 2002;39:116A.

  42. Prakash AM, Sun y, Chiaramida SA, Wu j, Lucariello RJ. Can two-dimensional echocardiography accurately measure pericardial effusion volume? J Am Coll Cardiol 2002;39:450A.

  43. Ricciardi MJ, Choi JW, Murphy SA, Davidson CJ, Kim RJ, Gibson CM. Myonecrosis following stent placement: association between impaired TIMI myocardial perfusion grade (TMPG) and MRI visualization of microinfarction. J Am Coll Card 2002;39;34A.

  44. Rosenson RS, Langman CB, Tangney CC, Brooks ER, Parker T, Levine D, Gordon B.  Simvastatin reduces bone turnover in hypercholesterolemia subjects independent of its effects on LDL oxidation and inflammatory markers.  J Am Coll Cardiol 2002;39:235A.

  45. Rosenson RS, Tangney CC, Parker T, Levine D, Gordon B.  Elevated soluble tumor necrosis factor receptor levels in healthy non-obese adults with the atherogenic dyslipoproteinemia.  Eur Heart J 2002;4(suppl):565.

  46. Rosenson RS, Tangney CC, Parker T, Levine D, Gordon B.  Statin therapy reduces oxidative stress and inhibits monocyte chemoattractant protein-1 (MCP-1) production in healthy adults with moderate hypercholesterolemia.  Circulation 2002;106:II-747.

  47. Russo RJ, Wong SC, Marchant D, Attubato M, Silva P, Korr K, Davidson C, Tuzcu M, Feldman T, Ling F. The Left Main IVUS Registry: angiographic and IVUS results. Circulation 2002;106:II-585.

  48. Sauer W, Passman R, Grubman E, Wong K, Ho R, Hanna M, Kocovic D, Pavri B. Coronary sinus ostium size Is associated with longer atrioventricular conduction times. J Am Coll Cardiol 2002;39:5A.

  49. Seghatol FF, Shah DJ, DiLuzio S, Bello D, Johnson MR, Cotts WG, Bonow RO, Gheorghiade M, Rigolin VH. Assesment of the magnitude and time course of improvement in echo score in heart failure patients receiving carvedilol using contractile reserve status. J Am Soc Echocardiogr 2002;15:517.

  50. Seghatol FF, Shah DJ, DiLuzio S, Bello D, Johnson MR, Cotts WG, O’Donohue JA, Bonow RO, Gheorghiade M, Rigolin VH. Reverse remodeling in heart failure patients receiving beta-blockers is associated with improved functional mitral regurgitation irrespective of severity of mitral regurgitation at baseline. Circulation 2002;106:II-525.

  51. Shah MR, Hasselblad V, Stevenson LW, Gattis WA, Gheorghiade M, Califf RM, O’Connor CM. Advanced heart failure patients unable to reach ACE inhibitor targets: a high risk population identified during hospitalization. J Am Coll Cardiol 2002;39:185A.

  52. Shors SM, Cotts WG, Surjancev-Pavlovic B, Francois CJ, Gheorghiade M, Johnson M, Niemczura RA, Finn JP. Analysis of cardioplumonary transit times in heart failure using time resolved magnetic resonance angiography. J Card Fail 2002;8:S24.

  53. Shors SM, Cotts WG, Surjancev-Pavlovic B, Francois CJ, Gheorghiade M, Johnson M, Niemczura RA, Finn JP. Non invasive cardiac evaluation in heart failure patients using MRI. J Card Fail 2002;8:S41.

  54. Taneja T, Horvath G, Racker D, Goldberger J, Kadish A:  Do changes in local cardiac electrophysiology influence ventricular fibrillation cycle length?  J Am Coll Cardiol 2002;39:92A.
    Tiukinhoy S, Khan A, Huang S, MacDonald R, McPherson D.  Novel acoustic azithromycin-encapsulated liposomes inhibit chlamydial growth in endothelial cells.  J Am Coll Cardiol 2002;39:396A.

  55. Unterreiner SC, McDermott MM, Tiukinhoy SD, Gluckman TJ, Liu K, Greenland P, Criqui MH, Guralnik JM.  The effects of exercise on lower extremity functioning in peripheral arterial disease patients without intermittent claudication: a randomized controlled clinical trial. J Invest Med 2002;5:240A.

  56. Wasserstrom JA: Relationships between Na+ pump current inhibition and inotropy differ for different ouabain analogs. Biophys J 2002;82:95a.

  57. Wu FI, Nagaraj A, Fildes JM, Davidson CJ, Mockros LF, McPherson DD.  Vascular acoustic emission parameters better identify and characterize angioplasty-induced injury. J Invest Med 2002;50:234A.

  58. Yan LL, Daviglus ML, Liu K, Garside DB, Greenland P, Stamler J.  Body mass index in middle age and Medicare diagnoses of coronary heart disease, cerebrovascular disease, and diabetes in old age. Circulation 2002;106:II-467.